Aclarion Inc.

8.63
0.05 (0.58%)
At close: Apr 11, 2025, 3:59 PM
9.20
6.60%
After-hours: Apr 11, 2025, 05:57 PM EDT
0.58%
Bid 8
Market Cap 5.02M
Revenue (ttm) 49.29K
Net Income (ttm) -6.27M
EPS (ttm) -5658.42
PE Ratio (ttm) n/a
Forward PE -0.05
Analyst Hold
Ask 9.35
Volume 37,914
Avg. Volume (20D) 208,502
Open 8.70
Previous Close 8.58
Day's Range 8.50 - 8.63
52-Week Range 7.26 - 6241.05
Beta 1.08

About ACON

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclari...

Sector Healthcare
IPO Date Apr 22, 2022
Employees 4
Stock Exchange NASDAQ
Ticker Symbol ACON
Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for ACON stock is "Hold." The 12-month stock price forecast is $481, which is an increase of 5473.58% from the latest price.

Stock Forecasts

Earnings Surprise

Aclarion has released their quartely earnings on Apr 9, 2025:
  • Revenue of $10.23K misses estimates by $7.27K, with -25.84% YoY decline.
  • EPS of -986.5 exceeds estimates by 370.24, with -64.58% YoY decline.
  • Next Earnings Release

    Aclarion Inc. is scheduled to release its earnings on May 14, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 week ago
    +11.49%
    Aclarion shares are trading higher after the compa... Unlock content with Pro Subscription
    2 weeks ago
    -23.05%
    Aclarion shares are trading lower after the company announced a 1-for-27 reverese stock split.